MA54374A - Formulation de médicament à libération retardée comprenant une couche externe avec un polymère dégradable par voie enzymatique, sa composition et son procédé de fabrication - Google Patents

Formulation de médicament à libération retardée comprenant une couche externe avec un polymère dégradable par voie enzymatique, sa composition et son procédé de fabrication

Info

Publication number: MA54374A
Authority: MA; Morocco
Prior art keywords: enzymaticly; composition; making; outer layer; delayed release
Prior art date: 2018-12-07

Application number

MA054374A

Other languages

English (en)

Inventor

Gonzalez Roberto Carlos Bravo

Carsten Markus Füller

Felipe Varum

Rochow Laetitia Von

Original Assignee

Tillotts Pharma Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2018-12-07

Filing date

2019-12-05

Publication date

2022-03-16

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=64661233&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA54374(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2019-12-05 Application filed by Tillotts Pharma Ag filed Critical Tillotts Pharma Ag

2022-03-16 Publication of MA54374A publication Critical patent/MA54374A/fr

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2893—Tablet coating processes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/606—Salicylic acid; Derivatives thereof having amino groups
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

MA054374A 2018-12-07 2019-12-05 Formulation de médicament à libération retardée comprenant une couche externe avec un polymère dégradable par voie enzymatique, sa composition et son procédé de fabrication MA54374A (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP18211152.6A EP3662901B1 (fr)	2018-12-07	2018-12-07	Formulation de médicaments à une liberation ralentie avec une couche extérieure comprenant un polymère dégradable par des enzymes, sa composition et son processus de production

Publications (1)

Publication Number	Publication Date
MA54374A true MA54374A (fr)	2022-03-16

Family

ID=64661233

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA054374A MA54374A (fr)	2018-12-07	2019-12-05	Formulation de médicament à libération retardée comprenant une couche externe avec un polymère dégradable par voie enzymatique, sa composition et son procédé de fabrication

Country Status (25)

Country	Link
US (1)	US12370146B2 (fr)
EP (2)	EP3662901B1 (fr)
JP (1)	JP7391966B2 (fr)
KR (1)	KR102802080B1 (fr)
CN (1)	CN113226292A (fr)
AR (1)	AR117681A1 (fr)
AU (2)	AU2019392854B2 (fr)
BR (1)	BR112021010914A2 (fr)
CA (2)	CA3281153A1 (fr)
CL (1)	CL2021001472A1 (fr)
CO (1)	CO2021008683A2 (fr)
CR (1)	CR20210366A (fr)
EA (1)	EA202191597A1 (fr)
ES (1)	ES3002632T3 (fr)
GE (1)	GEP20247608B (fr)
IL (1)	IL283718A (fr)
JO (1)	JOP20210136A1 (fr)
MA (1)	MA54374A (fr)
MX (2)	MX2021006603A (fr)
PH (1)	PH12021551292A1 (fr)
SG (1)	SG11202105691RA (fr)
TW (1)	TWI865473B (fr)
UA (1)	UA128938C2 (fr)
WO (1)	WO2020115255A1 (fr)
ZA (1)	ZA202103676B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20230118585A (ko) *	2020-12-08	2023-08-11	트리아스텍 인코포레이티드	야누스 키나아제(jak) 억제제의 지연된 지효성 경구 약물 제형 및 그 사용 방법
US20250319027A1 (en) *	2022-07-01	2025-10-16	Vitakey Inc.	Nutraceutical particles
KR20250163400A (ko) *	2023-03-31	2025-11-20	트리아스텍 인코포레이티드	대장 전달용 경구 약물 제형 및 이의 사용 및 제조 방법
CN118948789B (zh) *	2024-08-05	2025-04-01	山东丰金生物医药有限公司	一种稳定的美沙拉秦结肠定位释放组合物及其制备方法

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8812490D0 (en)	1988-05-26	1988-06-29	Agricultural & Food Res	Delayed release formulations
GB8926639D0 (en)	1989-11-24	1990-01-17	Agricultural & Food Res	Delayed release formulations
US5422121A (en)	1990-11-14	1995-06-06	Rohm Gmbh	Oral dosage unit form
US5914132A (en)	1993-02-26	1999-06-22	The Procter & Gamble Company	Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
US5656290A (en)	1993-02-26	1997-08-12	The Procter & Gamble Company	Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
US5482718A (en)	1994-03-23	1996-01-09	Hoffmann-La Roche Inc.	Colon-targeted delivery system
CN1239425A (zh)	1996-11-15	1999-12-22	普罗克特和甘保尔公司	供结肠释放的具有多层肠溶聚合物包衣的药剂
GB9722426D0 (en)	1997-10-23	1997-12-24	Univ London Pharmacy	Controlled release formulations
GB9724186D0 (en)	1997-11-14	1998-01-14	British Tech Group	Low temperature coatings
FI20000780A7 (fi)	2000-04-03	2001-10-04	Novasso Oy	Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi
GB2367002A (en)	2000-09-25	2002-03-27	British Sugar Plc	Coating composition
GB0203421D0 (en)	2002-02-13	2002-04-03	Alizyme Therapeutics Ltd	Composition
US7670627B2 (en)	2002-12-09	2010-03-02	Salvona Ip Llc	pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients
US9149439B2 (en)	2005-03-21	2015-10-06	Sandoz Ag	Multi-particulate, modified-release composition
DE102005032806A1 (de)	2005-07-12	2007-01-18	Röhm Gmbh	Verwendung eines teilneutralisierten, anionischen (Meth)acrylat-Copolymers als Überzug für die Herstellung einer Arzneiform mit einer Wirkstofffreisetzung bei erniedrigten pH-Werten
FR2899061B1 (fr)	2006-03-31	2009-07-31	Cid Lines Nv	Composition d'hygiene et/ou comestique et/ou desinfectante contenant au moins un agent anti-parasitaire repulsif et/ou insectifuge.
GB0607534D0 (en) *	2006-04-13	2006-05-24	Univ London Pharmacy	Colonic drug delivery formulation
AU2012247013B2 (en) *	2006-04-13	2016-01-14	University College London	Colonic drug delivery formulation
PT2152250T (pt)	2007-05-07	2019-12-12	Evonik Operations Gmbh	Formas farmacêuticas sólidas que compreendem um revestimento entérico com libertação acelerada do fármaco
ES2384305T3 (es) *	2008-02-19	2012-07-03	Mcneil-Ppc, Inc.	Composiciones de revestimiento por inmersión que contienen un almidón con elevado contenido de amilosa
MX2021000431A (es)	2011-03-23	2022-10-28	Ironshore Pharmaceuticals & Dev Inc	Metodos y composiciones para el tratamiento de trastorno por deficit de atencion.
HRP20192210T1 (hr)	2012-04-30	2020-02-21	Tillotts Pharma Ag	Formulacija lijeka s produženim otpuštanjem
ES2655622T3 (es)	2012-04-30	2018-02-20	Tillotts Pharma Ag	Una formulación de fármaco de liberación retardada
NZ717159A (en)	2013-10-29	2019-06-28	Tillotts Pharma Ag	A delayed release drug formulation
CN105412904A (zh)	2014-06-17	2016-03-23	深圳翰宇药业股份有限公司	利那洛肽肠溶缓释微丸胶囊制剂及其制备方法和用途
ES2874669T3 (es)	2016-02-09	2021-11-05	Albireo Ab	Formulación oral de colestiramina y uso de la misma
CN105832691B (zh)	2016-05-31	2018-10-02	深圳市健元医药科技有限公司	一种度拉糖肽结肠定位缓释制剂及其制备方法
EP3257501A1 (fr)	2016-06-14	2017-12-20	Tillotts Pharma AG	Forme galénique unitaire multiple comprenant un noyau avec différentes unités de coeur recouvertes par un matériau muco-adhésif et un revêtement noyau gastro-résistant
JP7516007B2 (ja)	2016-06-28	2024-07-16	セリバ・バイオロジクス・インコーポレイテッド	経口抗生物質からのマイクロバイオーム防御
WO2019032027A1 (fr)	2017-08-09	2019-02-14	Albireo Ab	Pastilles de cholestyramine, formulations orales de cholestyramine et leur utilisation
ES2994844T3 (en)	2018-12-07	2025-02-03	Tillotts Pharma Ag	Colonic drug delivery formulation
EP3662900A1 (fr)	2018-12-07	2020-06-10	Tillotts Pharma AG	Formulation d'administration de médicament colonique

2018
- 2018-12-07 ES ES18211152T patent/ES3002632T3/es active Active
- 2018-12-07 EP EP18211152.6A patent/EP3662901B1/fr active Active
2019
- 2019-12-04 TW TW108144379A patent/TWI865473B/zh active
- 2019-12-05 UA UAA202103934A patent/UA128938C2/uk unknown
- 2019-12-05 AU AU2019392854A patent/AU2019392854B2/en active Active
- 2019-12-05 JO JOP/2021/0136A patent/JOP20210136A1/ar unknown
- 2019-12-05 CA CA3281153A patent/CA3281153A1/en active Pending
- 2019-12-05 CN CN201980081115.9A patent/CN113226292A/zh active Pending
- 2019-12-05 EA EA202191597A patent/EA202191597A1/ru unknown
- 2019-12-05 JP JP2021532824A patent/JP7391966B2/ja active Active
- 2019-12-05 EP EP19816317.2A patent/EP3890710A1/fr active Pending
- 2019-12-05 BR BR112021010914-5A patent/BR112021010914A2/pt unknown
- 2019-12-05 MA MA054374A patent/MA54374A/fr unknown
- 2019-12-05 GE GEAP201915683A patent/GEP20247608B/en unknown
- 2019-12-05 US US17/309,554 patent/US12370146B2/en active Active
- 2019-12-05 WO PCT/EP2019/083910 patent/WO2020115255A1/fr not_active Ceased
- 2019-12-05 CR CR20210366A patent/CR20210366A/es unknown
- 2019-12-05 PH PH1/2021/551292A patent/PH12021551292A1/en unknown
- 2019-12-05 SG SG11202105691RA patent/SG11202105691RA/en unknown
- 2019-12-05 KR KR1020217020595A patent/KR102802080B1/ko active Active
- 2019-12-05 CA CA3122013A patent/CA3122013A1/fr active Pending
- 2019-12-05 MX MX2021006603A patent/MX2021006603A/es unknown
- 2019-12-09 AR ARP190103588A patent/AR117681A1/es unknown
2021
- 2021-05-28 ZA ZA2021/03676A patent/ZA202103676B/en unknown
- 2021-06-03 MX MX2024012397A patent/MX2024012397A/es unknown
- 2021-06-04 CL CL2021001472A patent/CL2021001472A1/es unknown
- 2021-06-06 IL IL283718A patent/IL283718A/en unknown
- 2021-06-30 CO CONC2021/0008683A patent/CO2021008683A2/es unknown
2025
- 2025-08-21 AU AU2025220793A patent/AU2025220793A1/en active Pending

Also Published As

Publication number	Publication date
EP3662901B1 (fr)	2025-01-01
JP7391966B2 (ja)	2023-12-05
US20220023222A1 (en)	2022-01-27
BR112021010914A2 (pt)	2021-08-24
AU2019392854B2 (en)	2025-06-26
CL2021001472A1 (es)	2021-12-24
US12370146B2 (en)	2025-07-29
JP2022511119A (ja)	2022-01-28
CA3122013A1 (fr)	2020-06-11
TW202038968A (zh)	2020-11-01
CR20210366A (es)	2021-11-23
ES3002632T3 (en)	2025-03-07
SG11202105691RA (en)	2021-06-29
CN113226292A (zh)	2021-08-06
EP3890710A1 (fr)	2021-10-13
AR117681A1 (es)	2021-08-25
ZA202103676B (en)	2022-10-26
MX2024012397A (es)	2024-11-08
CA3281153A1 (en)	2025-10-31
EP3662901C0 (fr)	2025-01-01
KR102802080B1 (ko)	2025-05-02
EP3662901A1 (fr)	2020-06-10
CO2021008683A2 (es)	2021-08-19
GEP20247608B (en)	2024-03-11
WO2020115255A1 (fr)	2020-06-11
JOP20210136A1 (ar)	2023-01-30
TWI865473B (zh)	2024-12-11
IL283718A (en)	2021-07-29
UA128938C2 (uk)	2024-12-04
MX2021006603A (es)	2021-08-24
EA202191597A1 (ru)	2021-08-30
AU2025220793A1 (en)	2025-09-11
PH12021551292A1 (en)	2022-03-28
KR20210100663A (ko)	2021-08-17
AU2019392854A1 (en)	2021-07-08

Publication	Publication Date	Title
MA54374A (fr)	2022-03-16	Formulation de médicament à libération retardée comprenant une couche externe avec un polymère dégradable par voie enzymatique, sa composition et son procédé de fabrication
EP3591749A4 (fr)	2020-06-17	Électrode multicouche et son procédé de fabrication
EP3741421A4 (fr)	2022-03-23	Micro-aiguille implantable et son procédé de fabrication
EP3476968A4 (fr)	2019-12-25	Acier trempé à chaud de faible densité et son procédé de fabrication
EP3581618C0 (fr)	2023-06-07	Composition de caoutchouc, et procédé de fabrication de celle-ci
EP3381469A4 (fr)	2019-07-31	Conjugué anticorps-médicament anti-erbb2 et composition à base de celui-ci, procédé de préparation associé et leur application
EP3480840A4 (fr)	2020-03-11	Film semi-conducteur d'oxyde et son procédé de fabrication
EP3479769A4 (fr)	2019-08-21	Endoscope à ultrasons et son procédé de fabrication
FR3053696B1 (fr)	2018-07-06	Composition de polyamide semi-cristallin de haute temperature de transition vitreuse pour materiau composite, son procede de fabrication et ses utilisations
EP3486275A4 (fr)	2020-03-04	Film d'étanchéité, et procédé de fabrication de celui-ci
EP3726570A4 (fr)	2021-11-03	Procédé de fabrication d'une structure de montage, et feuille utilisée dans celui-ci
EP3488699A4 (fr)	2019-05-29	Composition antibactérienne, film antibactérien, matériau de base avec film antibactérien, procédé de fabrication de film antibactérien, et procédé de fabrication de matériau de base avec film antibactérien
EP3660060A4 (fr)	2021-03-17	Polymère fluoré, composition d'agent de démoulage et procédé de démoulage
EP3553581A4 (fr)	2020-01-01	Structure de lentille, son procédé de fabrication et caméra
EP3376542A4 (fr)	2019-06-26	Élément d'imagerie à semi-conducteurs et son procédé de fabrication
EP3511351A4 (fr)	2019-10-23	Copolymère et son procédé de préparation
EP3521464A4 (fr)	2020-05-13	Matériau coulissant et son procédé de fabrication, et élément coulissant
EP3939575A4 (fr)	2022-10-26	Microparticules de plga, formulation à libération prolongée de celles-ci et leur procédé de fabrication
EP3627212A4 (fr)	2021-03-03	Composition de lentille de contact, et lentille de contact et son procédé de fabrication
EP3495394A4 (fr)	2020-03-18	Procédé de fabrication de polymère à base de diène conjugué modifié, et procédé de fabrication de composition de polymère
EP3907293A4 (fr)	2022-04-06	Biopuce, procédé de fabrication et application correspondants
EP3565000A4 (fr)	2020-03-18	Élément d'imagerie à semiconducteur et son procédé de fabrication
EP3608438A4 (fr)	2021-01-06	Cible en siliciure de tungstène et son procédé de fabrication
KR102127439B9 (ko)	2022-04-15	공액 미소공성 고분자 필름 및 이의 제조방법
EP3641730A4 (fr)	2020-06-24	Particule et composition pharmaceutique comprenant un composé de camptothécine insoluble ayant une double structure c ur-coque et son procédé de fabrication